AKT1 and kidney cancer: Corroborating our notion that this is a putative drug in kidney cancer, Villegas et al. [65] showed that the lipoxygenase inhibitor BW-B70C selectively killed human leukemic cells by dampening the NOTCH1-PI3K/AKT-eNOS axis.